POINT ROBERTS, Wash. and DELTA, British Columbia, March 28, 2019 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering
hemp and cannabis stocks releases a snapshot looking at how, as CBD gains momentum in the US, companies are eyeing the next
potential markets; mainly south of the border in Mexico and South America.
In November 2018, Mexico announced approval for the importation and sale of cannabis products at pharmacies and retailers across
the country to service the Mexican population of 130+ million. Sixty product licenses have been initially approved by the
COFEPRIS thus far, and it is expected this decision will make cannabis products like hemp-derived CBD available on the shelves of
general retailers across the nation.
CannaOne Technologies (CSE: CNNA), a company
that develops and markets various digital tools to service various segments for the cannabis industry in Canada, with its flagship
product BloomKit, is taking advantage of this new southern market potential. The company recently
announced entering into a formal agreement with Manna Health Services SA de CV of Mexico City, to undertake the development,
launch, and operation of an industry-leading, online CBD product purchase and delivery marketplace for the Country of Mexico. The
agreement was signed on March 5, 2019, with a contract term of 36 months and an option to renew for an additional 60 months at the
conclusion of the initial period.
"BloomKit, our enterprise software solution, will give Manna the capability to offer a flagship and fully operational online CBD
marketplace once Mexican regulations are finalized. For example, it will offer Manna the ability to inherently monitor and track
pick-up and delivery logistics, and the capability to deliver historical and current trending analytics to ensure optimal
management of all CBD sales channels. It will provide this all with the benefit of a simple and easy to use built-in eCommerce
solution."
Currently, Manna Health is approved by the Mexican government to buy, sell, lease, distribute, import, or export any products
related to health and wellness. Once this CBD marketplace has launched, Manna has further committed to CannaOne to jointly study,
analyze and utilize all market and consumer data that is collected and retained through the marketplace."
CANNAMERICA BRANDS CORP. (CSE: CANA) (OTCQB: CNNXF) is also
looking into Mexico for CBD, having announced that
it has entered into a binding letter of intent to create a joint venture with Sericea Labs S.A. de C.V. and CBDistribution Company
Ltd., with the intention of building a facility in Mexico for importing and warehousing licensed CBD products as well as CBD oils
and tinctures destined for refining.
When and if permitted under Mexican laws, the Company, SERICEA and CBDC also plan on acquiring, importing and cultivating
industrial hemp biomass for extraction into CBD isolate to be used for multiple product lines which utilize CBD. Subject to Board
approval from the Company and completion of satisfactory due diligence, the JV Parties intend to enter into a definitive joint
venture agreement on or before April 30, 2019.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), a
vertically integrated cannabis leader is focused not only on Mexico, but all of Latin America, having recently announced participating in Cosmoprof Worldwide Bologna, which took place March 14-17 in Bologna, Italy.
Kuida®, the first consumer brand for Khiron's wellness unit, brings the benefits of cannabidiol (CBD) to a comprehensive
portfolio of skin and body care products for women. Launched in Colombia in October 2018 through retail, wholesale and online
channels, Kuida® will now target the global skincare market which, according to Euromonitor International is expected to reach
US$131 Billion in 2019.
SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF) also put a
focus on international CBD in February, when the company announced the formation of a new international hemp-focused subsidiary, Heavenly Rx Ltd.
From the news:
"We are launching Heavenly Rx with the aim of acquiring a portfolio of battle-tested and proven hemp/CBD companies while also
acquiring certain unique brands for which we believe CBD and hemp-infused products could drastically change their growth," added
SOL's chief investment officer Andy DeFrancesco. "We are more bullish than ever about the future of the hemp and CBD industries
globally, and Heavenly Rx will without a doubt be the vertically integrated leader in the space. Heavenly Rx is not simply an
investment company, but rather a laser-focused global Hemp and CBD company only for all operations under the Heavenly Rx
banner."
CBD is already on the tip of everyone’s tongue in the US at the moment and it seems this “hype” is extending outward into the
Latin American community and Europe. The import/export of US CBD is expected to take off in 2019, and companies looking South and
East could gain a sizeable advantage due to the massive consumer populations available.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC,
NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
https://www.investorideas.com/About/
Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/
Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on
our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing,
content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for
each compensated news release, content published /created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring CannaOne Technologies Inc.
(CNNA.CN) is a paid for service on Investorideas.com – third party. Learn more about costs and our
services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Global
investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
